Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

Gimbel M.¹ , Qaderdan K.¹ , Willemsen L.¹ , Bergmeijer T.¹ , Kelder J.¹ , Deneer V.^{1, 12} , Ten Berg J.¹ , Hermanides R.² , De Vrey E.³ , Heestermans T.⁴ , Tjon Joe Gin M.⁵ , Waalewijn R. ⁶ , Hofma S.⁷ , Den Hartog F.⁸ , Jukema W.⁹ , Von Birgelen C.¹⁰ , Voskuil M.¹¹

Lancet

Elsevier Limited

10233

Английский

1374-1381

Опубликовано

395

2020

• ¹ Department of Cardiology|St Antonius Hospital
• ² Department of Clinical Pharmacy|Division of Laboratories|Pharmacy|and Biomedical Genetics University Medical Center Utrecht and Division of Pharmacoepidemiology and Clinical Pharmacology|Utrecht Institute for Pharmaceutical Sciences|Utrecht University
• ³ Department of Cardiology|Isala Hospitals
• ⁴ Department of Cardiology|Meander Medical Centre
• ⁵ Department of Cardiology|Noord-west Hospital group
• ⁶ Department of Cardiology
• ⁷ Department of Cardiology|Gelre Hospitals
• ⁸ Department of Cardiology|Medical Centre Leeuwarden
• ⁹ Department of Cardiology|Gelderse Vallei Hospital
• ¹⁰ Department of Cardiology|Leids University Medical Centre
• ¹¹ Department of Cardiology|Medisch Spectrum Twente
• ¹² Department of Cardiology|University Medical Centre Utrecht